High Glucose Promotes Aβ Production by Inhibiting APP Degradation

PLoS ONE

Volumn 8, Issue 7, 2013, Pages

  Yang, Yi ^a   Wu, Yili ^b   Zhang, Shuting ^a   Song, Weihong ^a,b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b CHILDREN S HOSPITAL OF CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN;

ALZHEIMER DISEASE; ARTICLE; CELL CULTURE; CELL LEVEL; CELL METABOLISM; DIABETES MELLITUS; DISEASE ASSOCIATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HYPERGLYCEMIA; NERVE CELL; PATHOGENESIS; PROTEIN DEGRADATION; PROTEIN METABOLISM; PROTEIN SYNTHESIS; RISK FACTOR;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; BRAIN MAPPING; CASE-CONTROL STUDIES; CELL PHYSIOLOGICAL PHENOMENA; FEMALE; FLUORODEOXYGLUCOSE F18; FOLLOW-UP STUDIES; GLUCOSE; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MILD COGNITIVE IMPAIRMENT; NEURAL NETWORKS (COMPUTER); NEUROIMAGING; POSITRON-EMISSION TOMOGRAPHY;

EID: 84880715461     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0069824     Document Type: Article

References (90)

1. Wimo A, Prince M (2010) World Alzheimer Report 2010: The Global Economic Impact of Dementia. Alzheimer's Disease International, London 1-56.
2. Querfurth HW, LaFerla FM, (2010) Alzheimer's Disease. New England Journal of Medicine 362: 329-344.
3. Reitz C, Brayne C, Mayeux R, (2011) Epidemiology of Alzheimer disease. Nat Rev Neurol 7: 137-152.
4. Goldgaber D, Lerman MI, McBride OW, Saffiotti U, Gajdusek DC, (1987) Characterization and chromosomal localization of a cDNA encoding brain amyloid of Alzheimer's disease. Science 235: 877-880.
5. Kang J, Lemaire HG, Unterbeck A, Salbaum JM, Masters CL, et al. (1987) The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor. Nature 325: 733-736.
6. Tanzi RE, Gusella JF, Watkins PC, Bruns GA, St George-Hyslop P, et al. (1987) Amyloid beta protein gene: cDNA, mRNA distribution, and genetic linkage near the Alzheimer locus. Science 235: 880-884.
7. Robakis NK, Ramakrishna N, Wolfe G, Wisniewski HM, (1987) Molecular cloning and characterization of a cDNA encoding the cerebrovascular and the neuritic plaque amyloid peptides. Proc Natl Acad Sci U S A 84: 4190-4194.
8. Neve RL, Finch EA, Dawes LR, (1988) Expression of the Alzheimer amyloid precursor gene transcripts in the human brain. Neuron 1: 669-677.
9. Tanzi RE, McClatchey AI, Lamperti ED, Villa-Komaroff L, Gusella JF, et al. (1988) Protease inhibitor domain encoded by an amyloid protein precursor mRNA associated with Alzheimer's disease. Nature 331: 528-530.
10. Zimmermann K, Herget T, Salbaum JM, Schubert W, Hilbich C, et al. (1988) Localization of the putative precursor of Alzheimer's disease-specific amyloid at nuclear envelopes of adult human muscle. EMBO J 7: 367-372.
11. Theuns J, Van Broeckhoven C, (2000) Transcriptional regulation of Alzheimer's disease genes: implications for susceptibility. Hum Mol Genet 9: 2383-2394.
12. Song W, Lahiri DK, (1998) Molecular cloning of the promoter of the gene encoding the Rhesus monkey beta-amyloid precursor protein: structural characterization and a comparative study with other species. Gene 217: 151-164.
13. Song W, Lahiri DK, (1998) Functional identification of the promoter of the gene encoding the Rhesus monkey beta-amyloid precursor protein. Gene 217: 165-176.
14. Goldgaber DES, Odenwald WF, (1991) Hox-1.3, amyloid β-protein precursor and aging BrainResRev. 16: 89-91.
15. Grilli M, Ribola M, Alberici A, Valerio A, Memo M, et al. (1995) Identification and characterization of a kappa B/Rel binding site in the regulatory region of the amyloid precursor protein gene. J Biol Chem 270: 26774-26777.
16. Goldgaber D, Harris HW, Hla T, Maciag T, Donnelly RJ, et al. (1989) Interleukin 1 regulates synthesis of amyloid beta-protein precursor mRNA in human endothelial cells. Proc Natl Acad Sci U S A 86: 7606-7610.
17. Konig G, Masters CL, Beyreuther K, (1990) Retinoic acid induced differentiated neuroblastoma cells show increased expression of the beta A4 amyloid gene of Alzheimer's disease and an altered splicing pattern. FEBS Lett 269: 305-310.
18. Mobley WC, Neve RL, Prusiner SB, McKinley MP, (1988) Nerve growth factor increases mRNA levels for the prion protein and the beta-amyloid protein precursor in developing hamster brain. Proc Natl Acad Sci U S A 85: 9811-9815.
19. Yoshikai S-i, Sasaki H, Doh-ura K, Furuya H, Sakaki Y, (1990) Genomic organization of the human amyloid beta-protein precursor gene. Gene 87: 257-263.
20. Dewji NN, Do C, Bayney RM, (1995) Transcriptional activation of Alzheimer's beta-amyloid precursor protein gene by stress. Brain Res Mol Brain Res 33: 245-253.
21. Abe K, St George-Hyslop PH, Tanzi RE, Kogure K, (1991) Induction of amyloid precursor protein mRNA after heat shock in cultured human lymphoblastoid cells. Neurosci Lett 125: 169-171.
22. Turner PR, O'Connor K, Tate WP, Abraham WC, (2003) Roles of amyloid precursor protein and its fragments in regulating neural activity, plasticity and memory. Prog Neurobiol 70: 1-32.
23. Weidemann A, Konig G, Bunke D, Fischer P, Salbaum JM, et al. (1989) Identification, biogenesis, and localization of precursors of Alzheimer's disease A4 amyloid protein. Cell 57: 115-126.
24. Caporaso GL, Takei K, Gandy SE, Matteoli M, Mundigl O, et al. (1994) Morphologic and biochemical analysis of the intracellular trafficking of the Alzheimer beta/A4 amyloid precursor protein. J Neurosci 14: 3122-3138.
25. Schubert W, Prior R, Weidemann A, Dircksen H, Multhaup G, et al. (1991) Localization of Alzheimer beta A4 amyloid precursor protein at central and peripheral synaptic sites. Brain Res 563: 184-194.
26. Shigematsu K, McGeer PL, McGeer EG, (1992) Localization of amyloid precursor protein in selective postsynaptic densities of rat cortical neurons. Brain Res 592: 353-357.
27. Tomimoto H, Akiguchi I, Wakita H, Nakamura S, Kimura J, (1995) Ultrastructural localization of amyloid protein precursor in the normal and postischemic gerbil brain. Brain Res 672: 187-195.
28. Cole GM, Bell L, Truong QB, Saitoh T, (1992) An endosomal-lysosomal pathway for degradation of amyloid precursor protein. Ann N Y Acad Sci 674: 103-117.
29. Haass C, Koo EH, Mellon A, Hung AY, Selkoe DJ, (1992) Targeting of cell-surface beta-amyloid precursor protein to lysosomes: alternative processing into amyloid-bearing fragments. Nature 357: 500-503.
30. Kaneko M, Koike H, Saito R, Kitamura Y, Okuma Y, et al. (2010) Loss of HRD1-mediated protein degradation causes amyloid precursor protein accumulation and amyloid-beta generation. J Neurosci 30: 3924-3932.
31. Georgopoulou N, McLaughlin M, McFarlane I, Breen KC (2001) The role of post-translational modification in beta-amyloid precursor protein processing. Biochem Soc Symp: 23-36.
32. Li Y, Zhou W, Tong Y, He G, Song W, (2006) Control of APP processing and Abeta generation level by BACE1 enzymatic activity and transcription. FASEB J 20: 285-292.
33. Deng Y, Wang Z, Wang R, Zhang X, Zhang S, et al. (2013) Amyloid-b protein (Ab) Glu11 is the major b-secretase site of b-site amyloid-b precursor protein-cleaving enzyme 1, and shifting the cleavage site to Ab Asp1 contributes to Alzheimer pathogenesis. Eur J Neurosci.
34. Ly PT, Wu Y, Zou H, Wang R, Zhou W, et al. (2013) Inhibition of GSK3beta-mediated BACE1 expression reduces Alzheimer-associated phenotypes. J Clin Invest 123: 224-235.
35. Ghosh AK, Gemma S, Tang J, (2008) beta-Secretase as a therapeutic target for Alzheimer's disease. Neurotherapeutics 5: 399-408.
36. Qing H, He G, Ly PT, Fox CJ, Staufenbiel M, et al. (2008) Valproic acid inhibits Abeta production, neuritic plaque formation, and behavioral deficits in Alzheimer's disease mouse models. J Exp Med 205: 2781-2789.
37. Esch FS, Keim PS, Beattie EC, Blacher RW, Culwell AR, et al. (1990) Cleavage of amyloid beta peptide during constitutive processing of its precursor. Science 248: 1122-1124.
38. Sisodia SS, Koo EH, Beyreuther K, Unterbeck A, Price DL, (1990) Evidence that beta-amyloid protein in Alzheimer's disease is not derived by normal processing. Science 248: 492-495.
39. Young-Pearse TL, Bai J, Chang R, Zheng JB, LoTurco JJ, et al. (2007) A critical function for beta-amyloid precursor protein in neuronal migration revealed by in utero RNA interference. J Neurosci 27: 14459-14469.
40. Leyssen M, Ayaz D, Hebert SS, Reeve S, De Strooper B, et al. (2005) Amyloid precursor protein promotes post-developmental neurite arborization in the Drosophila brain. EMBO J 24: 2944-2955.
41. Goate A, Chartier-Harlin MC, Mullan M, Brown J, Crawford F, et al. (1991) Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature 349: 704-706.
42. Oyama F, Cairns NJ, Shimada H, Oyama R, Titani K, et al. (1994) Down's syndrome: up-regulation of beta-amyloid protein precursor and tau mRNAs and their defective coordination. J Neurochem 62: 1062-1066.
43. Cheon MS, Dierssen M, Kim SH, Lubec G, (2008) Protein expression of BACE1, BACE2 and APP in Down syndrome brains. Amino Acids 35: 339-343.
44. Wu Y, Song W, (2013) Regulation of RCAN1 translation and its role in oxidative stress-induced apoptosis. FASEB J 27: 208-221.
45. Sun X, Wu Y, Chen B, Zhang Z, Zhou W, et al. (2011) Regulator of calcineurin 1 (RCAN1) facilitates neuronal apoptosis through caspase-3 activation. J Biol Chem 286: 9049-9062.
46. Brouwers N, Sleegers K, Engelborghs S, Bogaerts V, Serneels S, et al. (2006) Genetic risk and transcriptional variability of amyloid precursor protein in Alzheimer's disease. Brain 129: 2984-2991.
47. Rovelet-Lecrux A, Hannequin D, Raux G, Le Meur N, Laquerriere A, et al. (2006) APP locus duplication causes autosomal dominant early-onset Alzheimer disease with cerebral amyloid angiopathy. Nat Genet 38: 24-26.
48. Hebert SS, Horre K, Nicolai L, Bergmans B, Papadopoulou AS, et al. (2009) MicroRNA regulation of Alzheimer's Amyloid precursor protein expression. Neurobiol Dis 33: 422-428.
49. Matsui T, Ingelsson M, Fukumoto H, Ramasamy K, Kowa H, et al. (2007) Expression of APP pathway mRNAs and proteins in Alzheimer's disease. Brain Res 1161: 116-123.
50. Biessels GJ, Staekenborg S, Brunner E, Brayne C, Scheltens P, (2006) Risk of dementia in diabetes mellitus: a systematic review. Lancet Neurol 5: 64-74.
51. Kopf D, Frolich L, (2009) Risk of incident Alzheimer's disease in diabetic patients: a systematic review of prospective trials. J Alzheimers Dis 16: 677-685.
52. Brands AM, Biessels GJ, de Haan EH, Kappelle LJ, Kessels RP, (2005) The effects of type 1 diabetes on cognitive performance: a meta-analysis. Diabetes Care 28: 726-735.
53. Cukierman T, Gerstein HC, Williamson JD, (2005) Cognitive decline and dementia in diabetes-systematic overview of prospective observational studies. Diabetologia 48: 2460-2469.
54. Jolivalt CG, Hurford R, Lee CA, Dumaop W, Rockenstein E, et al. (2010) Type 1 diabetes exaggerates features of Alzheimer's disease in APP transgenic mice. Exp Neurol 223: 422-431.
55. Ke YD, Delerue F, Gladbach A, Gotz J, Ittner LM, (2009) Experimental diabetes mellitus exacerbates tau pathology in a transgenic mouse model of Alzheimer's disease. PLoS One 4: e7917.
56. Janson J, Laedtke T, Parisi JE, O'Brien P, Petersen RC, et al. (2004) Increased risk of type 2 diabetes in Alzheimer disease. Diabetes 53: 474-481.
57. Qing H, Zhou W, Christensen MA, Sun X, Tong Y, et al. (2004) Degradation of BACE by the ubiquitin-proteasome pathway. FASEB J 18: 1571-1573.
58. Abi-Saab WM, Maggs DG, Jones T, Jacob R, Srihari V, et al. (2002) Striking differences in glucose and lactate levels between brain extracellular fluid and plasma in conscious human subjects: effects of hyperglycemia and hypoglycemia. J Cereb Blood Flow Metab 22: 271-279.
59. Reinstrup P, Stahl N, Mellergard P, Uski T, Ungerstedt U, et al. (2000) Intracerebral microdialysis in clinical practice: baseline values for chemical markers during wakefulness, anesthesia, and neurosurgery. Neurosurgery 47: 701-709; discussion 709-710.
60. Queisser MA, Yao D, Geisler S, Hammes HP, Lochnit G, et al. (2010) Hyperglycemia impairs proteasome function by methylglyoxal. Diabetes 59: 670-678.
61. Peres GB, Juliano MA, Simoes MJ, Michelacci YM, (2013) Lysosomal enzymes are decreased in the kidney of diabetic rats. Biochim Biophys Acta 1832: 85-95.
62. Perlmuter LC, Hakami MK, Hodgson-Harrington C, Ginsberg J, Katz J, et al. (1984) Decreased cognitive function in aging non-insulin-dependent diabetic patients. Am J Med 77: 1043-1048.
63. Jagusch W, Voncramon DY, Renner R, Hepp KD, (1992) Cognitive function and metabolic state in elderly diabetic patients. Diabetes Nutrition & Metabolism 5: 265-274.
64. Carantoni M, Zuliani G, Munari MR, D'Elia K, Palmieri E, et al. (2000) Alzheimer disease and vascular dementia: relationships with fasting glucose and insulin levels. Dement Geriatr Cogn Disord 11: 176-180.
65. Razay G VAWG, (2007) The metabolic syndrome and alzheimer disease. Archives of Neurology 64: 93-96.
66. Nomura S, Komiyama Y, Miyake T, Miyazaki Y, Kido H, et al. (1994) Amyloid beta-protein precursor-rich platelet microparticles in thrombotic disease. Thromb Haemost 72: 519-522.
67. Russell JW, Golovoy D, Vincent AM, Mahendru P, Olzmann JA, et al. (2002) High glucose-induced oxidative stress and mitochondrial dysfunction in neurons. FASEB J 16: 1738-1748.
68. Yang Y, Quitschke WW, Brewer GJ, (1998) Upregulation of amyloid precursor protein gene promoter in rat primary hippocampal neurons by phorbol ester, IL-1 and retinoic acid, but not by reactive oxygen species. Molecular Brain Research 60: 40-49.
69. Caporaso GL, Gandy SE, Buxbaum JD, Greengard P, (1992) Chloroquine inhibits intracellular degradation but not secretion of Alzheimer beta/A4 amyloid precursor protein. Proc Natl Acad Sci U S A 89: 2252-2256.
70. Knops J, Lieberburg I, Sinha S, (1992) Evidence for a nonsecretory, acidic degradation pathway for amyloid precursor protein in 293 cells. Identification of a novel, 22-kDa, beta-peptide-containing intermediate. J Biol Chem 267: 16022-16024.
71. McFarlane I, Georgopoulou N, Coughlan CM, Gillian AM, Breen KC, (1999) The role of the protein glycosylation state in the control of cellular transport of the amyloid β precursor protein. Neuroscience 90: 15-25.
72. Tienari PJ, De Strooper B, Ikonen E, Simons M, Weidemann A, et al. (1996) The beta-amyloid domain is essential for axonal sorting of amyloid precursor protein. EMBO J 15: 5218-5229.
73. Yazaki M, Tagawa K, Maruyama K, Sorimachi H, Tsuchiya T, et al. (1996) Mutation of potential N-linked glycosylation sites in the Alzheimer's disease amyloid precursor protein (APP). Neuroscience Letters 221: 57-60.
74. Hare JF, (2006) Intracellular pathways of folded and misfolded amyloid precursor protein degradation. Archives of Biochemistry and Biophysics 451: 79-90.
75. Ando K, Oishi M, Takeda S, Iijima K, Isohara T, et al. (1999) Role of phosphorylation of Alzheimer's amyloid precursor protein during neuronal differentiation. J Neurosci 19: 4421-4427.
76. El Ayadi A, Stieren ES, Barral JM, Boehning D, (2012) Ubiquilin-1 regulates amyloid precursor protein maturation and degradation by stimulating K63-linked polyubiquitination of lysine 688. Proc Natl Acad Sci U S A 109: 13416-13421.
77. Andersen OM, Reiche J, Schmidt V, Gotthardt M, Spoelgen R, et al. (2005) Neuronal sorting protein-related receptor sorLA/LR11 regulates processing of the amyloid precursor protein. Proc Natl Acad Sci U S A 102: 13461-13466.
78. Lopez Salon M, Pasquini L, Besio Moreno M, Pasquini JM, Soto E, (2003) Relationship between beta-amyloid degradation and the 26S proteasome in neural cells. Exp Neurol 180: 131-143.
79. Nunan J, Shearman MS, Checler F, Cappai R, Evin G, et al. (2001) The C-terminal fragment of the Alzheimer's disease amyloid protein precursor is degraded by a proteasome-dependent mechanism distinct from gamma-secretase. Eur J Biochem 268: 5329-5336.
80. Nunan J, Williamson NA, Hill AF, Sernee MF, Masters CL, et al. (2003) Proteasome-mediated degradation of the C-terminus of the Alzheimer's disease beta-amyloid protein precursor: effect of C-terminal truncation on production of beta-amyloid protein. J Neurosci Res 74: 378-385.
81. Tseng BP, Green KN, Chan JL, Blurton-Jones M, LaFerla FM, (2008) Abeta inhibits the proteasome and enhances amyloid and tau accumulation. Neurobiol Aging 29: 1607-1618.
82. Authier F, Posner BI, Bergeron JJ, (1996) Insulin-degrading enzyme. Clin Invest Med 19: 149-160.
83. Farris W, Mansourian S, Chang Y, Lindsley L, Eckman EA, et al. (2003) Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivo. Proc Natl Acad Sci U S A 100: 4162-4167.
84. Vekrellis K, Ye Z, Qiu WQ, Walsh D, Hartley D, et al. (2000) Neurons regulate extracellular levels of amyloid beta-protein via proteolysis by insulin-degrading enzyme. J Neurosci 20: 1657-1665.
85. Pivovarova O, Gogebakan O, Pfeiffer AF, Rudovich N, (2009) Glucose inhibits the insulin-induced activation of the insulin-degrading enzyme in HepG2 cells. Diabetologia 52: 1656-1664.
86. Vincent AM, Russell JW, Low P, Feldman EL, (2004) Oxidative stress in the pathogenesis of diabetic neuropathy. Endocr Rev 25: 612-628.
87. Tong Y, Zhou W, Fung V, Christensen MA, Qing H, et al. (2005) Oxidative stress potentiates BACE1 gene expression and Abeta generation. J Neural Transm 112: 455-469.
88. Quiroz-Baez R, Rojas E, Arias C, (2009) Oxidative stress promotes JNK-dependent amyloidogenic processing of normally expressed human APP by differential modification of alpha-, beta- and gamma-secretase expression. Neurochem Int 55: 662-670.
89. Tamagno E, Guglielmotto M, Aragno M, Borghi R, Autelli R, et al. (2008) Oxidative stress activates a positive feedback between the gamma- and beta-secretase cleavages of the beta-amyloid precursor protein. J Neurochem 104: 683-695.
90. Oda A, Tamaoka A, Araki W, (2010) Oxidative stress up-regulates presenilin 1 in lipid rafts in neuronal cells. J Neurosci Res 88: 1137-1145.